Home ADNKronos New Published Study Demonstrates Safety and Feasibility of Filterlex Medical’s CAPTIS® Device in Providing Embolic Protection During TAVR
 

Immediapress

New Published Study Demonstrates Safety and Feasibility of Filterlex Medical’s CAPTIS® Device in Providing Embolic Protection During TAVR

 

(Adnkronos) - Peer-Reviewed EuroIntervention Journal Publishes First-in-Human Study Finding Filterlex Medical's CAPTIS® Embolic Protection Device Performed Well and is Safe During Transcatheter Aortic Valve Replacement (TAVR). CAESAREA, Israel, Nov. 15

I contenuti di VeneziePost sono a pagamento.
Per visualizzare questo articolo e tutti i nostri contenuti scegli tra queste opzioni
Sei già iscritto a VeneziePost?
Clicca qui sotto e inserisci le tue credenziali
Accedi
Facebook Twitter Linkedin Email